Scope Fluidics obtains patent protection for the PCR|ONE technology in China

Curiosity Diagnostics, owned by Scope Fluidics – a biotechnological company listed on NewConnect, owner of innovative medical diagnostics projects, obtained a Chinese patent which protects the key technology of the PCR|ONE system. This is another foreign patent obtained by the Company, which also means a monopoly in China on the commercial use of the unique module which is part of the PCR|ONE analyzer.

Read More